Skip to main content
TipRanks
Go Ultimate75% OFF

Zoetis (0M3Q) Share Price & Analysis

0 Followers

0M3Q Stock Chart & Stats

$83.36-$0.01(>-0.01%)
At close: 4:30 PM GMT
$70$75$80$85Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$83.09 - $84.93
52-Week Range
$68.58 - $137.50
Previous Close
$83.37
Volume
N/A
Average Volume (3M)
10.48K
Market Cap
$34.29B
Enterprise Value
$36.45B
Total Cash (Recent Filing)
$1.53B
Total Debt (Recent Filing)
$9.24B
Price to Earnings (P/E)
14.2
Beta
1.19
Next Earnings
Feb 16, 2027 (Est.)
Dividend Yield
2.54%

Bulls Say, Bears Say

Bulls Say

High Profitability And Cash Generation

Zoetis combines high margins with substantial operating and free cash flow, indicating that earnings are strongly cash-backed. This financial capacity supports research, commercial investment, dividends, and repurchases while helping the company sustain its competitive position through normal market cycles.

Diversified Animal Health Portfolio

Growth across livestock, international markets, and diagnostics provides meaningful diversification beyond pressured U.S. companion-animal products. This breadth can reduce dependence on any single franchise, support recurring customer relationships, and create multiple avenues for durable expansion.

Pipeline And Product Innovation

The planned launches and broader pipeline provide potential lifecycle extensions and new growth categories in animal health. Although contribution is expected to build gradually, continued approvals and innovation can refresh established franchises and support longer-term revenue durability.

Bears Say

Companion Animal And Dermatology Pressure

Companion-animal weakness, especially dermatology competition and Apoquel share loss, is affecting a strategically important product area. Persistent pressure could restrain revenue and earnings growth until newer products scale and the company stabilizes market share.

High Financial Leverage

Debt materially exceeds the equity base, reducing balance-sheet flexibility relative to the company’s otherwise strong profitability. If growth remains soft or financing costs stay elevated, leverage could constrain investment choices and increase sensitivity to weaker operating performance.

Demand And Margin Headwinds

Recent revenue contraction and lower margins indicate that demand, product mix, and competitive pricing are pressuring near-term earnings quality. Continued clinic-visit weakness and affordability concerns could prolong these headwinds before pipeline launches materially contribute.

Zoetis News

0M3Q FAQ

What was Zoetis’s price range in the past 12 months?
Zoetis lowest share price was $68.58 and its highest was $137.50 in the past 12 months.
What is Zoetis’s market cap?
Zoetis’s market cap is $34.29B.
When is Zoetis’s upcoming earnings report date?
Zoetis’s next earnings report is estimated for Feb 16, 2027 (not yet confirmed), which is in 90 days.
How were Zoetis’s earnings last quarter?
Zoetis released its earnings results on Nov 05, 2026. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.512 by $0.238.
Is Zoetis overvalued?
According to Wall Street analysts Zoetis’s price is currently Undervalued.
Does Zoetis pay dividends?
Zoetis pays a quarterly dividend of $0.53 which represents an annual dividend yield of 2.54%. See more information on Zoetis dividends here
What is Zoetis’s EPS estimate?
Zoetis’s EPS estimate is 1.21.
How many shares outstanding does Zoetis have?
Zoetis has 406,316,160 shares outstanding.
What happened to Zoetis’s price movement after its last earnings report?
Zoetis reported an EPS of $1.75 in its last earnings report, beating expectations of $1.512. Following the earnings report the stock price went down -5.296%.
Which hedge fund is a major shareholder of Zoetis?
Hedge funds hold Zoetis shares: the largest hedge-fund position in Zoetis is 1,404,334,810 shares, and hedge funds increased their holdings by 4.0M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology